This provider's $4.8M in total Medicare payments ranks in the 96th percentile of Rheumatology providers nationally.
Medicare payments to this provider grew 56% from 2014 to 2023.
AI-generated analysis based on Medicare payment data.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $142.86 | $56.74 | 2.52x | $86.12 | $291.2K | 5.4K | 2.8K |
| 2015 | $172.35 | $74.96 | 2.30x | $97.39 | $350.9K | 5.9K | 3.1K |
| 2016 | $165.73 | $68.13 | 2.43x | $97.60 | $448.3K | 7.6K | 3.8K |
| 2017 | $165.85 | $63.86 | 2.60x | $101.99 | $633.8K | 10.8K | 5.5K |
| 2018 | $149.11 | $50.19 | 2.97x | $98.92 | $595.1K | 10.5K | 5.4K |
| 2019 | $149.85 | $54.08 | 2.77x | $95.77 | $734.3K | 11.7K | 5.9K |
| 2020 | $145.52 | $46.47 | 3.13x | $99.05 | $468.6K | 9.3K | 5.0K |
| 2021 | $144.15 | $49.49 | 2.91x | $94.66 | $379.8K | 7.0K | 3.8K |
| 2022 | $134.54 | $47.89 | 2.81x | $86.65 | $397.0K | 7.2K | 3.8K |
| 2023 | $122.95 | $45.69 | 2.69x | $77.26 | $454.5K | 8.0K | 4.0K |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | 13.9K | $1.1M | $81.92 | 2.41x |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | 19.5K | $1.1M | $57.19 | 2.57x |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | 3.9K | $433.9K | $110.27 | 2.63x |
| 96401 | Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle | 5.4K | $343.6K | $63.20 | 2.59x |
| 20610 | Aspiration and/or injection of large joint or joint capsule | 6.3K | $318.7K | $50.88 | 3.11x |
| J7324 | Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 2.0K | $311.5K | $157.79 | 2.07x |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | 1.6K | $196.7K | $122.74 | 1.64x |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | 1.5K | $120.6K | $79.65 | 1.90x |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | 942 | $114.8K | $121.88 | 2.41x |
| J9310 | Injection, rituximab, 100 mg | 184 | $103.8K | $564.40 | 1.44x |
| J0897 | Injection, denosumab, 1 mg | 5.7K | $86.2K | $15.23 | 2.45x |
| 20611 | Aspiration and/or injection of major joint or joint capsule with recording and reporting using ultrasound guidance | 944 | $68.1K | $72.15 | 3.75x |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | 820 | $45.1K | $54.98 | 3.59x |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 1.0K | $39.7K | $38.78 | 2.55x |
| J1745 | Injection infliximab, 10 mg | 684 | $38.5K | $56.23 | 2.10x |
| 96415 | Infusion of chemotherapy into a vein | 1.5K | $33.8K | $22.91 | 7.53x |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | 192 | $30.9K | $161.19 | 2.42x |
| 20600 | Aspiration and/or injection of small joint or joint capsule | 778 | $29.8K | $38.36 | 2.84x |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | 1.6K | $27.1K | $16.98 | 2.39x |
| 96375 | Injection of different drug or substance into a vein for therapy, diagnosis, or prevention | 1.1K | $15.9K | $14.69 | 6.15x |
This provider submits charges 2.58 times higher than what Medicare actually pays.
A markup ratio of 2.58x means for every $100 Medicare pays, this provider initially charges $258. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data